The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib.
The ubiquitin-proteasome system plays a key regulatory role in cellular homeostasis. The inhibition of the 26S proteasome by Bortezomib leads to the accumulation of misfolded proteins, resulting in endoplasmic reticulum stress followed by a coordinated cellular response called unfolded protein respo...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2009
|
| _version_ | 1797053856795852800 |
|---|---|
| author | Milani, M Rzymski, T Mellor, H Pike, L Bottini, A Generali, D Harris, A |
| author_facet | Milani, M Rzymski, T Mellor, H Pike, L Bottini, A Generali, D Harris, A |
| author_sort | Milani, M |
| collection | OXFORD |
| description | The ubiquitin-proteasome system plays a key regulatory role in cellular homeostasis. The inhibition of the 26S proteasome by Bortezomib leads to the accumulation of misfolded proteins, resulting in endoplasmic reticulum stress followed by a coordinated cellular response called unfolded protein response (UPR). Endoplasmic reticulum stress is also a potent inducer of macroautophagy. Bortezomib is a selective and potent inhibitor of the 26S proteasome and is approved for the treatment of multiple myeloma. Clinical trials with Bortezomib have shown promising results for some types of cancers, but not for some others, including those of the breast. In this study, we show that Bortezomib induces the UPR and autophagy in MCF7 breast cancer cells. Surprisingly, Bortezomib did not induce phosphorylation of PERK, a key initial step of the UPR. We show that induction of autophagy by Bortezomib is dependent on the proteasomal stabilisation of ATF4 and up-regulation of LC3B by ATF4. We show that ATF4 and LC3B play a critical role in activating autophagy and protecting cells from Bortezomib-induced cell death. Our experiments also reveal that HDAC6 knockdown results in decreased LC3B protein and reduced autophagy. Our work shows that the induction of autophagy through ATF4 may be an important resistance mechanism to Bortezomib treatment in breast cancer, and targeting autophagy may represent a novel approach to sensitize breast cancers to Bortezomib. |
| first_indexed | 2024-03-06T18:49:24Z |
| format | Journal article |
| id | oxford-uuid:0fad6eb9-ff0f-405f-9f09-345f38c0d6a1 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:49:24Z |
| publishDate | 2009 |
| record_format | dspace |
| spelling | oxford-uuid:0fad6eb9-ff0f-405f-9f09-345f38c0d6a12022-03-26T09:52:29ZThe role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0fad6eb9-ff0f-405f-9f09-345f38c0d6a1EnglishSymplectic Elements at Oxford2009Milani, MRzymski, TMellor, HPike, LBottini, AGenerali, DHarris, AThe ubiquitin-proteasome system plays a key regulatory role in cellular homeostasis. The inhibition of the 26S proteasome by Bortezomib leads to the accumulation of misfolded proteins, resulting in endoplasmic reticulum stress followed by a coordinated cellular response called unfolded protein response (UPR). Endoplasmic reticulum stress is also a potent inducer of macroautophagy. Bortezomib is a selective and potent inhibitor of the 26S proteasome and is approved for the treatment of multiple myeloma. Clinical trials with Bortezomib have shown promising results for some types of cancers, but not for some others, including those of the breast. In this study, we show that Bortezomib induces the UPR and autophagy in MCF7 breast cancer cells. Surprisingly, Bortezomib did not induce phosphorylation of PERK, a key initial step of the UPR. We show that induction of autophagy by Bortezomib is dependent on the proteasomal stabilisation of ATF4 and up-regulation of LC3B by ATF4. We show that ATF4 and LC3B play a critical role in activating autophagy and protecting cells from Bortezomib-induced cell death. Our experiments also reveal that HDAC6 knockdown results in decreased LC3B protein and reduced autophagy. Our work shows that the induction of autophagy through ATF4 may be an important resistance mechanism to Bortezomib treatment in breast cancer, and targeting autophagy may represent a novel approach to sensitize breast cancers to Bortezomib. |
| spellingShingle | Milani, M Rzymski, T Mellor, H Pike, L Bottini, A Generali, D Harris, A The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. |
| title | The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. |
| title_full | The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. |
| title_fullStr | The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. |
| title_full_unstemmed | The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. |
| title_short | The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. |
| title_sort | role of atf4 stabilization and autophagy in resistance of breast cancer cells treated with bortezomib |
| work_keys_str_mv | AT milanim theroleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT rzymskit theroleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT mellorh theroleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT pikel theroleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT bottinia theroleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT generalid theroleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT harrisa theroleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT milanim roleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT rzymskit roleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT mellorh roleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT pikel roleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT bottinia roleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT generalid roleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib AT harrisa roleofatf4stabilizationandautophagyinresistanceofbreastcancercellstreatedwithbortezomib |